eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | allergic bronchopulmonary aspergillosis |
| Comorbidity | C0004096|asthma |
| Sentences | 25 |
| PubMedID- 26187954 | allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
| PubMedID- 24199804 | The prevalence of abpa in asthma clinics may be as high as 13% with a global burden of almost 5 million patients. |
| PubMedID- 24748808 | Thus, although ige levels may be helpful in the diagnosis of allergic bronchopulmonary aspergillosis, with features of asthma and eosinophilia, the total ige has little utility in evaluation of most patients with asthma. |
| PubMedID- 22794691 | allergic bronchopulmonary aspergillosis (abpa) occurs in patients with asthma or cystic fibrosis resulting in pulmonary infiltrates, tenacious mucus plugs that harbor hyphae of aspergillus fumigatus, elevations of total serum ige concentration and peripheral blood, and sputum eosinophilia. |
| PubMedID- 22880030 | The asthmatic samples (asthma with or without abpa) had a significantly greater median protein concentration compared to the healthy control samples (p<0.001), with concentrations of 0.843 mg/ml (iqr: 0.535–1.086) and 0.355 mg/ml (iqr: 0.330–0.391) respectively. |
| PubMedID- 22410255 | Diagnostic parameters of abpa include asthma, roentgenographic fleeting pulmonary opacities, central bronchiectasis, type i and type iii hypersensitivity to a. fumigatus antigens (discussed in more depth below), and increased peripheral blood eosinophilia [22]. |
| PubMedID- 21860713 | Hrct of the chest should not be used in screening or in the initial diagnostic work up of asthmatics, as asthma without abpa can manifest with findings of cb. |
| PubMedID- 23827645 | Background and objective: the prevalence of allergic bronchopulmonary aspergillosis (abpa) in patients with bronchial asthma remains unknown. |
| PubMedID- 22794704 | Total serum ige can be measured and is helpful in determining atopic presentations such as in allergic bronchopulmonary aspergillosis or in patients with persistent asthma who are candidates for monoclonal anti-ige antibody therapy with, omalizumab. |
| PubMedID- 25354514 | allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
| PubMedID- 24082619 | Bronchial asthma with abpa presenting as pte. |
| PubMedID- 25640470 | Background: allergic bronchopulmonary aspergillosis (abpa) often presents with persistently uncontrolled asthma despite the use of corticosteroids and antifungal therapy. |
| PubMedID- 23210682 | Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. |
| PubMedID- 19207831 | Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in north india. |
| PubMedID- 25620428 | The diagnostic criteria for allergic bronchopulmonary aspergillosis in children with poorly controlled asthma need to be re-evaluated. |
| PubMedID- 24479057 | allergic bronchopulmonary aspergillosis (abpa) commonly presents with persistently uncontrolled asthma, despite of the therapy with highest possible anti-asthma medications. |
| PubMedID- 22971061 | The current retrospective study evaluated the use of newer azoles (voriconazole and posaconazole) in adult asthmatic patients with either abpa or severe asthma with fungal sensitization, and found the newer azoles to improve asthma control and reduce the severity of abpa. |
| PubMedID- 21603163 | allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. |
| PubMedID- 26005342 | abpa classically occurs in patients with asthma or cystic fibrosis, but cases in patients with copd or non-cystic fibrosis bronchiectasis have also been described. |
| PubMedID- 25753544 | Allergic broncho-pulmonary aspergillosis (abpa) affects patients with asthma or cystic fibrosis. |
| PubMedID- 21402950 | Aspergillus fumigatus is commonly associated with allergic bronchopulmonary aspergillosis in patients with severe asthma in which chronic airway neutrophilia predicts a poor outcome. |
| PubMedID- 22222946 | It is well known that abpa can occur in patients with asthma, but it has recently been reported in patients with copd as well. |
| PubMedID- 21179536 | The prevalence of abpa in asthma is as high as 19% whereas the prevalence in cystic fibrosis ranges from 6–10%. |
| PubMedID- 22223932 | The clinical presentation of abpa is usually with poorly controlled asthma, hemoptysis, expectoration of mucus plugs, malaise, and fever. |
| PubMedID- 21034574 | Aspirin induced asthma accompanied with allergic bronchopulmonary aspergillosis: a case report. |
Page: 1